Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000757701 | SCV000291954 | likely benign | not provided | 2021-09-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000335704 | SCV000394019 | benign | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000335704 | SCV000642076 | benign | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000757701 | SCV000886023 | likely benign | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | The PSTPIP1 c.1151A>G: p.Asp384Gly variant (rs200771233), to our knowledge, is not reported in the medical literature or in gene-specific databases. The variant is listed in the ClinVar database (Variation ID: 242305) and in the Genome Aggregation Database in 0.7% (221/30776 alleles, 2 homozygotes) of the South Asian population. The aspartic acid at this position is weakly conserved but computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Considering the increased allele frequency and the presence of homozygotes, this variant is considered likely benign. |
Genome Diagnostics Laboratory, |
RCV002262845 | SCV002542851 | likely benign | Autoinflammatory syndrome | 2021-05-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000757701 | SCV002545294 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | PSTPIP1: BS2 |
Genome Diagnostics Laboratory, |
RCV000757701 | SCV001978428 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000757701 | SCV001980458 | likely benign | not provided | no assertion criteria provided | clinical testing |